<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="2afe7385-2441-4e22-b63e-ab8614b275df"><labelDrug name="Sotalol hydrochloride"><Normalization/></labelDrug><generic name="Sotalol hydrochloride"/><sentence biomedicalEntities="2" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21" lineNumber="23" text="The use of sotalol in conjunction with other drugs that prolong the QT interval has not been studied and is not recommended. " type="regular"><entity charOffset="11:18" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.0" text="sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="The use of sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="45:79" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.1" text="drugs that prolong the QT interval" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="in conjunction with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="108:123" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.2" text="not recommended" type="Caution_Interaction"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.1" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.21.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22" text="Such drugs include many antiarrhythmics, some phenothiazines, tricyclic antidepressants, and certain oral macrolides. " type="negative"><entity charOffset="106:116" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.0" text="macrolides" type="Biomedical_Entity"><Normalization><mmtx cui="C0282563" phraseText="certain oral macrolides." preferredWord="Macrolides" semType="phsu, orch"/><RxNorm RxCui="1437086"/></Normalization></entity><entity charOffset="62:87" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.1" text="tricyclic antidepressants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants," preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="46:60" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.2" text="phenothiazines" type="Biomedical_Entity"><Normalization><mmtx cui="C0304370" phraseText="some phenothiazines," preferredWord="Phenothiazine derivatives" semType="phsu, orch"/><RxNorm RxCui="1437064"/></Normalization></entity><entity charOffset="24:39" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.3" text="antiarrhythmics" type="Biomedical_Entity"><Normalization><mmtx cui="C0003195" phraseText="many antiarrhythmics," preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.1" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.0"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.2" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.0"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.3" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.0"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.2" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.1"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.3" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.1"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.3" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.22.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23" lineNumber="23" text="Class I or Class III antiarrhythmic agents should be withheld for at least three half-lives prior to dosing with sotalol. " type="regular"><entity charOffset="0:7|21:42" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.0" text="Class I antiarrhythmic agents" type="Drug_Class"><Normalization><mmtx cui="C0360703" phraseText="Class III antiarrhythmic agents" preferredWord="Class III antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="11:42" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.1" text="Class III antiarrhythmic agents" type="Drug_Class"><Normalization><mmtx cui="C0360703" phraseText="Class III antiarrhythmic agents" preferredWord="Class III antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="50:61" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.2" text="be withheld" type="Caution_Interaction"/><entity charOffset="113:120" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.4" text="sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="with sotalol." preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.4" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.2" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.1" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.4" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.2" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.23.e.1"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.24" text="In clinical trials, sotalol was not administered to patients previously treated with oral amiodarone for &gt;1 month in the previous three months. " type="negative"><entity charOffset="20:27" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.24.e.0" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="90:100" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.24.e.1" text="amiodarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002598" phraseText="treated with oral amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.24.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.24.e.1"/></sentence><sentence biomedicalEntities="7" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25" lineNumber="23" text="Class Ia antiarrhythmic drugs, such as disopyramide, quinidine and procainamide and other Class III drugs (e.g., amiodarone) are not recommended as concomitant therapy with intravenous sotalol because of their potential to prolong refractoriness. " type="regular"><entity charOffset="0:29" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.0" text="Class Ia antiarrhythmic drugs" type="Drug_Class"><Normalization><mmtx cui="C0304503" phraseText="Class Ia antiarrhythmic drugs," preferredWord="Class Ia antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="39:51" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.1" text="disopyramide" type="Drug"><Normalization><mmtx cui="C0012702" phraseText="such as disopyramide," preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="53:62" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="67:79" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.3" text="procainamide" type="Drug"><Normalization><mmtx cui="C0033216" phraseText="procainamide" preferredWord="Procainamide" semType="phsu, orch"/><RxNorm RxCui="155056"/></Normalization></entity><entity charOffset="90:105" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.4" text="Class III drugs" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="other Class III drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="113:123" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.5" text="amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="173:192" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.10" text="intravenous sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="with intravenous sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="223:245" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.11" text="prolong refractoriness" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.5" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.4"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.1" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.0"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.2" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.0"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.3" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.0"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.11"><relations><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.10" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.11" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.4" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.10" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.11" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.25.e.4"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.29" lineNumber="27" text="Bradycardia itself increases the risk of Torsade de Pointes, so carefully monitor patients receiving concomitant digoxin." type="irregular"><entity charOffset="74:81" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.29.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="113:120" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.29.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="concomitant digoxin." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.29.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.29.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.29.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.28" text="In studies of oral sotalol, the incidence of bradycardia (as determined by the investigators) in the supraventricular arrhythmia population treated with oral sotalol was 13% and led to discontinuation in 2.4%. "><entity charOffset="14:26" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.28.e.0" text="oral sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="of oral sotalol," preferredWord="Sotalol" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.29.e.2"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.51" text="Hypersensitivity to catecholamines has been observed in patients withdrawn from beta-blocker therapy. " type="negative"><entity charOffset="20:34" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.51.e.0" text="catecholamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="Hypersensitivity to catecholamines" preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><entity charOffset="80:92" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.51.e.1" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="withdrawn from beta-blocker therapy." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.51.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.51.e.1"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.53" text="Therefore, when discontinuing chronically administered sotalol, particularly in patients with ischemic heart disease, carefully monitor the patient and consider the temporary use of an alternative beta-blocker if appropriate. " type="negative"><entity charOffset="197:209" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.53.e.0" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the temporary use of an alternative beta-blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="55:62" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.53.e.1" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="chronically administered sotalol," preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.53.e.1" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.53.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.60" lineNumber="53" text="Special attention should be given to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or patients receiving concomitant diuretic drugs." type="irregular"><entity charOffset="159:173" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.60.e.0" text="diuretic drugs" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitant diuretic drugs." preferredWord="Diuretics" semType="phsu"/><mmtx cui="C0013227" phraseText="concomitant diuretic drugs." preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="8:17" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.60.e.1" text="attention" type="Caution_Interaction"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.60.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.60.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.59" text="Sotalol should not be used in patients with hypokalemia or hypomagnesemia prior to correction of imbalance, as these conditions increase the potential for Torsade de Pointes. "><entity charOffset="0:7" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.59.e.0" text="Sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="Sotalol" preferredWord="Sotalol" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.60.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.60.e.0"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.66" text="If sotalol is to be administered, use the smallest effective dose, to minimize inhibition of bronchodilation produced by endogenous or exogenous catecholamine stimulation of beta2 receptors." type="negative"><entity charOffset="145:158" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.66.e.0" text="catecholamine" type="Biomedical_Entity"><Normalization><mmtx cui="C3536742" phraseText="exogenous catecholamine stimulation of beta2 receptors." preferredWord="Catecholamine [EPC]" semType="phsu"/><RxNorm RxCui="2146"/></Normalization></entity><entity charOffset="3:10" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.66.e.1" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.66.e.1" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.66.e.0"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74" text="While taking beta-blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic, or therapeutic. " type="negative"><entity charOffset="93:102" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74.e.0" text="allergens" type="Biomedical_Entity"><Normalization><mmtx cui="C3274161" phraseText="of allergens" preferredWord="Allergen (brand of diphenylpyraline)" semType="phsu, orch"/><RxNorm RxCui="1297244"/></Normalization></entity><entity charOffset="13:26" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="taking beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74.e.1" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.75" lineNumber="73" text="Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction." type="irregular"><entity charOffset="21:33" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.75.e.0" text="unresponsive" type="Decrease_Interaction"/><entity charOffset="56:67" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.75.e.2" text="epinephrine" type="Drug"><Normalization><mmtx cui="C0014563" phraseText="unresponsive to the usual doses of epinephrine" preferredWord="Epinephrine" semType="phsu, orch, horm, nsba"/><RxNorm RxCui="362"/></Normalization></entity><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.75.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.75.e.0"><relations><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.75.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74" text="While taking beta-blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic, or therapeutic. "><entity charOffset="13:26" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74.e.0" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="taking beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasContext"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74" text="While taking beta-blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic, or therapeutic. "><entity charOffset="44:76" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.74.e.1" text="history of anaphylactic reaction" type="SPAN"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.78" text="Protracted severe hypotension and difficulty in restoring and maintaining normal cardiac rhythm after anesthesia have been reported in patients receiving beta-blockers." type="negative"><entity charOffset="102:112" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.78.e.0" text="anesthesia" type="Biomedical_Entity"><Normalization><mmtx cui="C0002932" phraseText="maintaining normal cardiac rhythm after anesthesia" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="239756"/></Normalization></entity><entity charOffset="154:167" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.78.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.78.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.78.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83" lineNumber="87" text="Proarrhythmic events were more common in sotalol treated patients also receiving digoxin; " type="regular"><entity charOffset="0:20" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.0" text="Proarrhythmic events" type="Specific_Interaction"/><entity charOffset="41:48" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.2" text="sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="more common in sotalol treated patients also" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="81:88" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.3" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="0:20" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.4" text="Proarrhythmic events" type="SPAN"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.2" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.3" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.83.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86" lineNumber="91" text="Sotalol and calcium blocking drugs can be expected to have additive effects on atrioventricular conduction, ventricular function, and blood pressure." type="regular"><entity charOffset="0:7" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.0" text="Sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="Sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="12:34" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.1" text="calcium blocking drugs" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium blocking drugs" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="59:78|134:148" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.2" text="additive effects on blood pressure" type="Specific_Interaction"/><entity charOffset="59:106" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.4" text="additive effects on atrioventricular conduction" type="Specific_Interaction"/><entity charOffset="59:78|108:128" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.6" text="additive effects on ventricular function" type="Specific_Interaction"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.ddi.2"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.ddi.3"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.1" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" lineNumber="95" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. " type="regular"><entity charOffset="19:48" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.0" text="catecholamine-depleting drugs" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="Concomitant use of catecholamine-depleting drugs," preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C0013227" phraseText="Concomitant use of catecholamine-depleting drugs," preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C3536742" phraseText="Concomitant use of catecholamine-depleting drugs," preferredWord="Catecholamine [EPC]" semType="phsu"/><mmtx cui="C0013227" phraseText="Concomitant use of catecholamine-depleting drugs," preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="990350"/></Normalization></entity><entity charOffset="58:67" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.1" text="reserpine" type="Drug"><Normalization><mmtx cui="C0035179" phraseText="such as reserpine" preferredWord="Reserpine" semType="phsu, orch"/><RxNorm RxCui="9260"/></Normalization></entity><entity charOffset="72:84" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.2" text="guanethidine" type="Drug"><Normalization><mmtx cui="C0018318" phraseText="guanethidine," preferredWord="Guanethidine" semType="phsu, orch"/><RxNorm RxCui="5036"/></Normalization></entity><entity charOffset="93:105" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.5" text="beta-blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="with a beta-blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="121:176" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.6" text="excessive reduction of resting sympathetic nervous tone" type="Specific_Interaction"><Normalization><mmtx cui="C0027769" phraseText="an excessive reduction of resting sympathetic nervous tone." preferredWord="Nervousness" semType="sosy"/></Normalization></entity><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.1" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.0"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.2" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.0"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.6"><relations><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.5" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89" lineNumber="95" text="Monitor such patients for hypotension and marked bradycardia which may produce syncope." type="irregular"><entity charOffset="26:37" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.e.0" text="hypotension" type="Specific_Interaction"/><entity charOffset="49:60" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.e.2" text="bradycardia" type="Specific_Interaction"/><entity charOffset="79:86" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.e.4" text="syncope" type="Specific_Interaction"><Normalization><mmtx cui="C0039070" phraseText="syncope." preferredWord="Syncope" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. "><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.5"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. "><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.ddi.2"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.e.2"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. "><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.5"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. "><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.ddi.3"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89.e.4"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. "><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.5"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. "><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.90" text="7.4 Insulin and Oral Antidiabetic Agents" type="negative"><entity charOffset="4:11" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.90.e.0" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C1579433" phraseText="7.4 Insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="21:40" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.90.e.1" text="antidiabetic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0935929" phraseText="Oral Antidiabetic Agents" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.90.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.90.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91" lineNumber="99" text="Hyperglycemia may occur, and the dosage of insulin or antidiabetic drugs may require adjustment. " type="irregular"><entity charOffset="0:13" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.0" text="Hyperglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020456" phraseText="Hyperglycemia" preferredWord="Hyperglycemia" semType="dsyn"/></Normalization></entity><entity charOffset="54:72" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.2" text="antidiabetic drugs" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="43:50" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.3" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="the dosage of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="the dosage of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="the dosage of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="33:39|85:95" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.4" text="dosage adjustment" type="Caution_Interaction"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86" text="Sotalol and calcium blocking drugs can be expected to have additive effects on atrioventricular conduction, ventricular function, and blood pressure."><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.0"/></ellipsisSentence><middleSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.87" text="7.3 Catecholamine-Depleting Agents"/><middleSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. "/><middleSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89" text="Monitor such patients for hypotension and marked bradycardia which may produce syncope."/><middleSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.90" text="7.4 Insulin and Oral Antidiabetic Agents"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.ddi.2"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86" text="Sotalol and calcium blocking drugs can be expected to have additive effects on atrioventricular conduction, ventricular function, and blood pressure."><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.86.e.0"/></ellipsisSentence><middleSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.87" text="7.3 Catecholamine-Depleting Agents"/><middleSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.88" text="Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone. "/><middleSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.89" text="Monitor such patients for hypotension and marked bradycardia which may produce syncope."/><middleSentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.90" text="7.4 Insulin and Oral Antidiabetic Agents"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.91.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="5" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94" lineNumber="103" text="Beta-agonists such as albuterol, terbutaline and isoproterenol may have to be administered in increased dosages when used concomitantly with sotalol." type="regular"><entity charOffset="0:13" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.0" text="Beta-agonists" type="Drug_Class"><Normalization><mmtx cui="C0243192" phraseText="Beta-agonists such as albuterol," preferredWord="agonists" semType="phsu"/><mmtx cui="C2987634" phraseText="Beta-agonists such as albuterol," preferredWord="Agonist" semType="phsu"/><RxNorm RxCui="1437024"/></Normalization></entity><entity charOffset="22:31" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.1" text="albuterol" type="Drug"><Normalization><mmtx cui="C0001927" phraseText="Beta-agonists such as albuterol," preferredWord="Albuterol" semType="phsu, orch"/><mmtx cui="C0001927" phraseText="Beta-agonists such as albuterol," preferredWord="Albuterol" semType="phsu, orch"/><RxNorm RxCui="142153"/></Normalization></entity><entity charOffset="33:44" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.2" text="terbutaline" type="Drug"><Normalization><mmtx cui="C0039542" phraseText="terbutaline" preferredWord="Terbutaline" semType="phsu, orch"/><RxNorm RxCui="10368"/></Normalization></entity><entity charOffset="49:62" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.3" text="isoproterenol" type="Drug"><Normalization><mmtx cui="C0022245" phraseText="isoproterenol" preferredWord="Isoproterenol" semType="phsu, orch"/><RxNorm RxCui="82030"/></Normalization></entity><entity charOffset="141:148" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.4" text="sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="concomitantly with sotalol." preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="78:111" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.8" text="administered in increased dosages" type="Decrease_Interaction"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.1" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.0"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.2" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.0"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.3" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.0"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.8"><relations><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.4" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.94.e.8" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98" text="Sotalol has not been studied with other drugs that prolong the QT interval, such as antiarrhythmics, some phenothiazines, tricyclic antidepressants, and certain oral macrolides. " type="negative"><entity charOffset="0:7" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.0" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="Sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="166:176" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.1" text="macrolides" type="Biomedical_Entity"><Normalization><mmtx cui="C0003240" phraseText="certain oral macrolides." preferredWord="Macrolide Antibiotics" semType="orch, antb"/><RxNorm RxCui="1437086"/></Normalization></entity><entity charOffset="106:120" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.2" text="phenothiazines" type="Biomedical_Entity"><Normalization><mmtx cui="C0031436" phraseText="some phenothiazines," preferredWord="Phenothiazines" semType="phsu, orch"/><RxNorm RxCui="1437064"/></Normalization></entity><entity charOffset="84:99" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.3" text="antiarrhythmics" type="Biomedical_Entity"><Normalization><mmtx cui="C0003195" phraseText="such as antiarrhythmics," preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><entity charOffset="122:147" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.4" text="tricyclic antidepressants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants," preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.1"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.2"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.3"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.4"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.2" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.1"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.3" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.1"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.4" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.1"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.3" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.2"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.2" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.4"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.3" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.98.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99" lineNumber="111" text="Class I or Class III antiarrhythmic agents should be withheld for at least three half-lives prior to dosing with sotalol. " type="regular"><entity charOffset="0:7|21:42" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.0" text="Class I antiarrhythmic agents" type="Drug_Class"><Normalization><mmtx cui="C0360703" phraseText="Class III antiarrhythmic agents" preferredWord="Class III antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="11:42" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.1" text="Class III antiarrhythmic agents" type="Drug_Class"><Normalization><mmtx cui="C0360703" phraseText="Class III antiarrhythmic agents" preferredWord="Class III antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="53:61|92:107" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.2" text="withheld prior to dosing" type="Caution_Interaction"/><entity charOffset="113:120" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.4" text="sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="with sotalol." preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.4" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.2" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.1" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.4" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.2" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.99.e.1"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.100" text="In clinical trials, sotalol was not administered to patients previously treated with oral amiodarone for &gt;1 month in the previous three months. " type="negative"><entity charOffset="20:27" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.100.e.0" text="sotalol" type="Biomedical_Entity"><Normalization><mmtx cui="C0037707" phraseText="sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="7008"/></Normalization></entity><entity charOffset="90:100" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.100.e.1" text="amiodarone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002598" phraseText="treated with oral amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.100.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.100.e.1"/></sentence><sentence biomedicalEntities="7" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101" lineNumber="111" text="Class Ia antiarrhythmic drugs, such as disopyramide, quinidine and procainamide and other Class III drugs (e.g., amiodarone) are not recommended as concomitant therapy with intravenous sotalol because of their potential to prolong refractoriness [see Warnings and Precautions (5)]. " type="regular"><entity charOffset="0:29" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.0" text="Class Ia antiarrhythmic drugs" type="Drug_Class"><Normalization><mmtx cui="C0304503" phraseText="Class Ia antiarrhythmic drugs," preferredWord="Class Ia antiarrhythmic drug" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="39:51" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.1" text="disopyramide" type="Drug"><Normalization><mmtx cui="C0012702" phraseText="such as disopyramide," preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="53:62" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="67:79" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.3" text="procainamide" type="Drug"><Normalization><mmtx cui="C0033216" phraseText="procainamide" preferredWord="Procainamide" semType="phsu, orch"/><RxNorm RxCui="155056"/></Normalization></entity><entity charOffset="90:105" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.7" text="Class III drugs" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="other Class III drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="5716"/></Normalization></entity><entity charOffset="113:123" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.8" text="amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="173:192" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.10" text="intravenous sotalol" type="Drug"><Normalization><mmtx cui="C0037707" phraseText="with intravenous sotalol" preferredWord="Sotalol" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="223:245" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.11" text="prolong refractoriness" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.1" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.0"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.2" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.0"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.3" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.0"/><drugClassMembership drug="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.8" drugClass="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.7"/><drugInteraction id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.ddi.1"><interaction trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.11"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.10"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.7" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.10" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.11" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.10" trigger="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.11" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.0" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.101.e.7"/></sentence><sentence id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.104" text="No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin." type="negative"><entity charOffset="74:82" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.104.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="51:70" id="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.104.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="observed with hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.104.e.1" e2="Dailymed.2afe7385-2441-4e22-b63e-ab8614b275df.s.104.e.0"/></sentence><positiveExamples number="15"/><negativeExamples number="29"/></document>